雇用主・職場の薬物検査の市場規模、シェア、動向分析レポート：タイプ別、製品別、モード別、薬物別、最終用途別、地域別、セグメント予測、2024年～2030年

雇用主・職場の薬物検査市場の成長と動向：

Grand View Research, Incの最新レポートによると、世界の雇用主・職場の薬物検査の市場規模は、2030年までに79億6,000万米ドルに達すると予測され、2024年から2030年までのCAGRは4.5%で成長すると予測されています。

この市場を牽引しているのは、生産性を向上させ、労働災害を減らすために、薬物のない職場を維持することへの注目が高まっていることであり、薬物検査サービスの需要をさらに促進しています。

薬物乱用の蔓延と、それに伴うパフォーマンスの低下や欠勤の増加などのリスクの高まりが、雇用主による包括的な薬物検査プログラムの実施を後押ししています。迅速かつ正確な検出技術など、検査方法の技術的進歩は、薬物検査プロセスの効率性と信頼性を向上させることで市場の成長に寄与しています。政府のイニシアチブと資金提供プログラムの増加は、市場成長をさらに促進しています。例えば、米国政府は2022年12月に2023年統合歳出法（公法117-328）（CAA23）を制定しました。この法律は、2023会計年度の資金を物質乱用・精神衛生サービス局（SAMHSA）に割り当て、SAMHSAの物質使用障害と精神衛生に関するプログラムを強化、再承認、拡大するさまざまな条項を盛り込みました。

世界中の多くの政府が、職場における薬物乱用の認識と防止を促進するためのキャンペーンを開始し、資金を提供し、プログラムを確立しています。こうした取り組みには、特にリスクが高いと見なされる業種において、従業員の薬物検査を奨励または義務付けるガイドラインや枠組みが含まれることが多いです。その結果、雇用主は政府の方針に沿って薬物検査を導入することが増え、これらのプログラムを遵守することで提供される奨励金や資金から利益を得るようになっています。

安全のために薬物・アルコール検査を義務付けている様々な政府機関による規制の厳格な施行により、雇用主や職場の薬物検査製品に対する需要はさらに高まると予想されます。Federal Drug-Free Workplace Programのガイドラインによると、SAMHSA薬物乱用防止センターがHHS認定試験所を監督しています。これらの薬物検査プログラムは、国家安全保障、法執行、公衆衛生・安全など、機密性の高い職務に就く従業員に義務付けられています。政府機関も非政府組織も、薬物使用に対処するため、新製品の発売、提携、M&Aなどの戦略的イニシアチブを実施しており、これが市場の成長に寄与しています。

同市場の主な参入企業は以下の通りで、First Advantage、Laboratory Corporation of America Holdings（Labcorp）、Dragerwerk AG &Co.KGaA、Bio-Rad Laboratories, Inc.、Abbott、Clinical Reference Laboratory Inc.、Quest Diagnostics、Cordant Health Solutions、DISA Global Solutions、HireRight, LLC、OraSure Technologies, Inc.、Omega Laboratories、Psychemedics Corporationなどは、世界的に患者に対応するため、製品の発売買収や特許に焦点を当てたリソースの立ち上げなど、重要な戦略的イニシアチブを採用しています。例えば、2024年5月、eMedはi3screenと提携し、雇用主向けの新しい仮想薬物スクリーニング・プログラムを導入しました。この革新的なサービスにより、企業は遠隔で薬物検査を実施することができ、プロセスがより便利で効率的になります。この提携により、雇用主は管理が簡単で迅速な結果を提供する仮想薬物スクリーニングを提供できるようになり、雇用とコンプライアンス手続きの合理化に役立ちます。

雇用主・職場の薬物検査市場のレポートハイライト

• タイプ別では、雇用後セグメントが2023年に77.9%の最大売上シェアで市場をリードしました。雇用後薬物検査では、雇用後の従業員をスクリーニングし、通常、職場の薬物ポリシーの継続的な遵守を監視します。
• 消耗品セグメントは、2023年に33.3%の最大売上シェアで市場をリードしました。消耗品は薬物検査において重要な役割を果たしています。これらの製品の市場は、高品質でコンプライアンスに準拠した検査ソリューションの必要性、技術の進歩、薬物のない職場の維持が重視されるようになったことが背景にあります。市場の主要企業は、雇用主の進化するニーズと規制基準を満たすために、多様な消耗品の開発と提供に注力しています。
• モード別では、尿セグメントが2023年に41.5%の最大売上シェアで市場をリードしました。これは、雇用主や職場の薬物検査目的で採尿が増加していることに起因しています。処方されたレジメンを遵守し、物質の誤用や乱用を防ぐための重要なツールが尿薬物モニタリング（UDM）です。
• 薬物別では、大麻／マリファナ分野が2023年に57.9%の最大売上シェアで市場をリードしました。これは、さまざまな国で医療用および娯楽用の大麻が合法化されたことにより、雇用主や職場の薬物検査要件が増加したことに起因します。より多くの人々が大麻を消費するにつれて、雇用主やヘルスケアプロバイダーはその使用を検出し監視しようとしています。
• 最終用途別では、その他の専門サービス分野が2023年に38.6％の最大収益シェアで市場をリードしました。多様な専門サービス分野の企業が、規制要件の遵守、法的責任のリスク管理、職場の安全性向上のために薬物検査プログラムを採用する傾向が強まっています。
• 北米は、主要プレイヤーの存在と、Quest Diagnostics、LabCorp、Bio-Rad Laboratoriesなどの著名プレイヤーを含む、相当数の雇用主・職場の薬物検査ラボを擁していることから、2023年に48.8%の最大収益シェアで市場を独占しました。米国は、職場の薬物検査に対する需要の高まりとヘルスケア環境での適用の増加により、この地域で最大の市場として際立っています。カナダも重要な役割を果たしており、ヘルスケアと職場の両方で薬物検査が顕著に伸びています。さらに、北米地域は大麻検査のような新興市場を特徴としており、市場拡大をさらに促進すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の雇用主・職場の薬物検査市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連 / 補助的な市場見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
• 世界の雇用主・職場の薬物検査市場分析ツール
  • 業界分析 - ポーターのファイブフォース分析
  • PESTEL分析

第4章 世界の雇用主・職場の薬物検査市場：タイプの推定・動向分析

• セグメントダッシュボード
• 世界の雇用主・職場の薬物検査市場のタイプ変動分析
• 世界の雇用主・職場の薬物検査市場の規模と動向分析、タイプ別、2018年～2030年
• 雇用前薬物検査
• 雇用後

第5章 世界の雇用主・職場の薬物検査市場：製品の推定・動向分析

• セグメントダッシュボード
• 世界の雇用主・職場の薬物検査市場の製品変動分析
• 世界の雇用主・職場の薬物検査市場の規模と動向分析、製品別、2018年～2030年
• 消耗品
• 機器
• 迅速検査装置
• サービス

第6章 世界の雇用主・職場の薬物検査市場：モードの推定・動向分析

• セグメントダッシュボード
• 世界の雇用主・職場の薬物検査市場のモード変動分析
• 世界の雇用主・職場の薬物検査市場の規模と動向分析、モード別、2018～2030年
• 尿
• 髪
• 口腔液
• 即時テスト

第7章 世界の雇用主・職場の薬物検査市場：薬物の推定・動向分析

• セグメントダッシュボード
• 世界の雇用主・職場の薬物検査市場の薬物変動分析
• アルコール
• 大麻 / マリファナ
• コカイン
• オピオイド
• アンフェタミン・メタンフェタミン
• LSD
• その他

第8章 世界の雇用主・職場の薬物検査市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 世界の雇用主・職場の薬物検査市場の最終用途変動分析
• IT / 金融
• 製造業
• 輸送
• 建設
• 小売業・ホスピタリティ
• ヘルスケア
• 教育
• その他の専門サービス

第9章 雇用主・職場の薬物検査市場：地域の推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018年～2030年：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 企業 / 競合の分類
• 戦略マッピング
• 企業市場シェア分析、2023年
• 主要な認証プロバイダー / スキーム所有者のリスト
• 企業プロファイル / 上場企業
  • First Advantage
  • Laboratory Corporation of America Holdings（Labcorp）
  • Dragerwerk AG & Co. KGaA
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Clinical Reference Laboratory Inc.
  • Quest Diagnostics
  • Cordant Health Solutions
  • DISA Global Solutions
  • HireRight, LLC
  • OraSure Technologies, Inc.
  • Psychemedics Corporation
  • Omega Laboratories

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviation
• Table 3 U.S. employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 4 U.S. employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 5 U.S. employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 6 U.S. employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 7 U.S. employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 8 North America employer and workplace drug testing market, by region, 2018 - 2030 (USD Million)
• Table 9 North America employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 10 North America employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 11 North America employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 12 North America employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 13 North America employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 14 Canada employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 15 Canada employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 16 Canada employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 17 Canada employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 18 Canada employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 19 Mexico employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 20 Mexico employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 21 Mexico employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 22 Mexico employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 23 Mexico employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 24 Europe employer and workplace drug testing market, by region, 2018 - 2030 (USD Million)
• Table 25 Europe employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 26 Europe employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 27 Europe employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 28 Europe employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 29 Europe employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 30 UK employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 31 UK employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 32 UK employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 33 UK employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 34 UK employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 35 Germany employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 36 Germany employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 37 Germany employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 38 Germany employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 39 Germany employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 40 France employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 41 France employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 42 France employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 43 France employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 44 France employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 45 Italy employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 46 Italy employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 47 Italy employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 48 Italy employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 49 Italy employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 50 Spain employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 51 Spain employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 52 Spain employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 53 Spain employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 54 Spain employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 55 Denmark employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 56 Denmark employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 57 Denmark employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 58 Denmark employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 59 Denmark employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 60 Sweden employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 61 Sweden employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 62 Sweden employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 63 Sweden employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 64 Sweden employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 65 Norway employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 66 Norway employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 67 Norway employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 68 Norway employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 69 Norway employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 70 Asia Pacific employer and workplace drug testing market, by region, 2018 - 2030 (USD Million)
• Table 71 Asia Pacific employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 72 Asia Pacific employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 73 Asia Pacific employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 74 Asia Pacific employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 75 Asia Pacific employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 76 Japan employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 77 Japan employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 78 Japan employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 79 Japan employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 80 Japan employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 81 China employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 82 China employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 83 China employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 84 China employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 85 China employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 86 India employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 87 India employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 88 India employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 89 India employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 90 India employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 91 Australia employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 92 Australia employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 93 Australia employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 94 Australia employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 95 Australia employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 96 South Korea employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 97 South Korea employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 98 South Korea employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 99 South Korea employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 100 South Korea employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 101 Thailand employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 102 Thailand employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 103 Thailand employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 104 Thailand employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 105 Thailand employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 106 Latin America employer and workplace drug testing market, by region, 2018 - 2030 (USD Million)
• Table 107 Latin America employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 108 Latin America employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 109 Latin America employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 110 Latin America employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 111 Latin America employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 112 Brazil employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 113 Brazil employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 114 Brazil employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 115 Brazil employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 116 Brazil employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 117 Argentina employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 118 Argentina employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 119 Argentina employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 120 Argentina employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 121 Argentina employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 122 MEA employer and workplace drug testing market, by region, 2018 - 2030 (USD Million)
• Table 123 MEA employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 124 MEA employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 125 MEA employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 126 MEA employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 127 MEA employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 128 South Africa employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 129 South Africa employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 130 South Africa employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 131 South Africa employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 132 South Africa employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 133 Saudi Arabia employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 134 Saudi Arabia employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 135 Saudi Arabia employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 136 Saudi Arabia employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 137 Saudi Arabia employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 138 UAE employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 139 UAE employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 140 UAE employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 141 UAE employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 142 global employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 143 Kuwait employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
• Table 144 Kuwait employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
• Table 145 Kuwait employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
• Table 146 Kuwait employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 147 Kuwait employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Global employer and workplace drug testing market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segment snapshot-1
• Fig. 14 Segment snapshot-2
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Market trends & outlook
• Fig. 17 Porter's five force analysis
• Fig. 18 PESTEL analysis
• Fig. 19 Global employer and workplace drug testing market: Type outlook key takeaways
• Fig. 20 Global employer and workplace drug testing market: Type movement analysis
• Fig. 21 Pre-employment drug screens market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Post-employment market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Global employer and workplace drug testing market: Product outlook key takeaways
• Fig. 24 Global employer and workplace drug testing market: Product movement analysis
• Fig. 25 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Rapid testing devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Global employer and workplace drug testing market: Mode outlook key takeaways
• Fig. 30 Global employer and workplace drug testing market: Mode movement analysis
• Fig. 31 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Hair market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Oral fluid market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Instant testing estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Global employer and workplace drug testing market: Mode outlook key takeaways
• Fig. 36 Global employer and workplace drug testing market: Mode movement analysis
• Fig. 37 Alcohol market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Cannabis/marijuana market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Cocaine market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Opioids estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Amphetamine & methamphetamine market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 LSD market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Global employer and workplace drug testing market: End-use outlook key takeaways
• Fig. 45 Global employer and workplace drug testing market: End-use movement analysis
• Fig. 46 IT/finance market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Construction estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Retail and hospitality market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Education market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Other professional services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Employer and Workplace Drug Testing Market: Regional outlook and key takeaways
• Fig. 55 Regional outlook, 2023 & 2030
• Fig. 56 North America
• Fig. 57 North America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 US key country dynamics
• Fig. 59 US market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Canada key country dynamics
• Fig. 61 Canada market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Europe
• Fig. 63 Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 UK key country dynamics
• Fig. 65 UK market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 Germany
• Fig. 67 Germany market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 France key country dynamics
• Fig. 69 France market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 Italy key country dynamics
• Fig. 71 Italy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 Spain key country dynamics
• Fig. 73 Spain market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Denmark key country dynamics
• Fig. 75 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 76 Sweden key country dynamics
• Fig. 77 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Norway key country dynamics
• Fig. 79 Norway market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Asia-Pacific
• Fig. 81 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 82 Japan key country dynamics
• Fig. 83 Japan market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 84 China key country dynamics
• Fig. 85 China market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 86 India key country dynamics
• Fig. 87 India market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 South Korea key country dynamics
• Fig. 89 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 90 Australia key country dynamics
• Fig. 91 Australia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 Thailand key country dynamics
• Fig. 93 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 94 Latin America
• Fig. 95 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 96 Brazil key country dynamics
• Fig. 97 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 98 Mexico key country dynamics
• Fig. 99 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 100 Argentina key country dynamics
• Fig. 101 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 102 Middle East & Africa
• Fig. 103 MEA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 104 South Africa key country dynamics
• Fig. 105 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 106 Saudi Arabia key country dynamics
• Fig. 107 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 108 UAE key country dynamics
• Fig. 109 UAE market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 110 Kuwait key country dynamics
• Fig. 111 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 112 Market differentiators
• Fig. 113 Key company market share analysis, 2023

Employer And Workplace Drug Testing Market Growth & Trends:

The global employer and workplace drug testing market size is anticipated to reach USD 7.96 billion by 2030 and is projected to grow at a CAGR of 4.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing focus on maintaining a drug-free workplace to enhance productivity and reduce workplace accidents further propels demand for drug testing services.

The rising prevalence of substance abuse and its associated risks, including impaired performance and increased absenteeism, drives employers to implement comprehensive drug testing programs. Technological advancements in testing methods, such as rapid and accurate detection technologies, contribute to market growth by improving the efficiency and reliability of drug testing processes. Rising government initiative and funding programs is further driving market growth. For instance, in December 2022, the U.S. government enacted the Consolidated Appropriations Act 2023 (Public Law 117-328) (CAA 23). This legislation allocated funds to the Substance Abuse and Mental Health Services Administration (SAMHSA) for the fiscal year 2023 and included various provisions that reinforced, reauthorized, and expanded SAMHSA's programs for substance use disorders and mental health.

Many governments around the world are launching campaigns, providing funding, and establishing programs to promote awareness and prevention of substance abuse in the workplace. These initiatives often include guidelines and frameworks that encourage or mandate drug testing among employees, particularly in industries deemed high-risk. As a result, employers are increasingly adopting drug testing practices to align with government policies and benefit from incentives or funding provided for compliance with these programs.

The demand for employer and workplace drug testing products is further anticipated to increase due to the rigorous enforcement of regulations by various government agencies that mandate drug and alcohol testing for safety purposes. According to the Federal Drug-Free Workplace Program's guidelines, the SAMHSA Center for Substance Abuse Prevention oversees HHS-certified laboratories. These drug-testing programs are required for employees in sensitive roles, such as those in national security, law enforcement, and public health and safety. Both government and non-governmental organizations are implementing strategic initiatives, including new product launches, partnerships, and mergers and acquisitions, to address drug use, which contributes to the growth of the market.

Some of the key players in the market are. First Advantage; Laboratory Corporation of America Holdings (Labcorp); Dragerwerk AG & Co. KGaA; Bio-Rad Laboratories, Inc.; Abbott; Clinical Reference Laboratory Inc.; Quest Diagnostics; Cordant Health Solutions; DISA Global Solutions; HireRight, LLC; OraSure Technologies, Inc.; Omega Laboratories; Psychemedics Corporation and other are adopting key strategic initiatives such as product launches acquisition and launching patent focused resources to cater patients globally. For instance, in May 2024, eMed collaborated with i3screen to introduce a new virtual drug screening program for employers. This innovative service allows companies to conduct drug tests remotely, making the process more convenient and efficient. With this partnership, employers can now offer virtual drug screenings that are easy to administer and provide quick results, helping to streamline their hiring and compliance procedures.

Employer And Workplace Drug Testing Market Report Highlights:

• Based on type, the post-employment segment led the market with the largest revenue share of 77.9% in 2023. Post-employment drug testing involves screening employees after they have been hired, typically to monitor ongoing compliance with workplace drug policies
• The consumables segment led the market with the largest revenue share of 33.3% in 2023. Consumables play an important role in drug testing. Market for these products is driven by the need for high-quality and compliant testing solutions, advancements in technology, and the increasing emphasis on maintaining a drug-free workplace. Key players in the market focus on developing and providing a diverse range of consumables to meet the evolving needs of employers and regulatory standards
• Based on mode, the urine segment led the market with the largest revenue share of 41.5% in 2023. This can be attributed to increasing urine collection for employer and workplace drug testing purposes. A crucial tool for adhering to a prescribed regimen and preventing substance misuse or abuse is Urine Drug Monitoring (UDM)
• Based on drug, the cannabis/marijuana segment led the market with the largest revenue share of 57.9% in 2023. This is attributable to the legalization of cannabis for medical and recreational use in various countries has led to an increase in employer and workplace drug testing requirements. As more people consume cannabis, employers and healthcare providers are seeking to detect and monitor its use
• Based on end use, the other professional services segment led the market with the largest revenue share of 38.6% in 2023. Companies across diverse professional services are increasingly adopting drug testing programs to comply with regulatory requirements, manage liability risks, and enhance workplace safety
• North America dominated the market with the largest revenue share of 48.8% in 2023, due to the presence of a key players and the region hosts a significant number of employer and workplace drug testing laboratories, including prominent players such as Quest Diagnostics, LabCorp, and Bio-Rad Laboratories. The U.S. stands out as the largest market in the region, driven by the rising demand for workplace drug testing and its increasing application in healthcare settings. Canada also plays a key role, with notable growth in drug testing within both healthcare and workplace environments. In addition, the North American region features emerging markets, such as cannabis testing, which is anticipated to further fuel market expansion.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Type Segment
  • 1.2.2. Product Segment
  • 1.2.3. Mode Segment
  • 1.2.4. Drug Segment
  • 1.2.5. End-use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Global Employer and Workplace Drug Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising demand for pre-employment testing
    • 3.2.1.2. Stringent laws mandating alcohol and drug testing in the workplace
    • 3.2.1.3. Rising prevalence of substance use in the workplace
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Changing legal environment and changing societal norms
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Technological advancement in drug testing for workplace
• 3.3. Global Employer and Workplace Drug Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Global Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Employer and Workplace Drug Testing Market Type Movement Analysis
• 4.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by type, 2018 to 2030 (USD Million)
• 4.4. Pre-employment Drug Screens
  • 4.4.1. Pre-employment drug screens market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Post-employment
  • 4.5.1. Post-employment market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Employer and Workplace Drug Testing Market Product Movement Analysis
• 5.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
• 5.4. Consumables
  • 5.4.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Instruments
  • 5.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Rapid Testing Devices
  • 5.6.1. Rapid testing devices market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Services
  • 5.7.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Employer and Workplace Drug Testing Market Mode Movement Analysis
• 6.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by mode, 2018 to 2030 (USD Million)
• 6.4. Urine
  • 6.4.1. Urine market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Hair
  • 6.5.1. Hair market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Oral Fluid
  • 6.6.1. Oral fluid market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Instant testing
  • 6.7.1. Instant testing market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Employer and Workplace Drug Testing Market Drug Movement Analysis
  • 7.2.1. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by drug, 2018 to 2030 (USD Million)
• 7.3. Alcohol
  • 7.3.1. Alcohol market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Cannabis/Marijuana
  • 7.4.1. Cannabis/marijuana market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Cocaine
  • 7.5.1. Cocaine market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Opioids
  • 7.6.1. Opioids testing market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Amphetamine & Methamphetamine
  • 7.7.1. Amphetamine & methamphetamine market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. LSD
  • 7.8.1. LSD market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. Others
  • 7.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Global Employer and Workplace Drug Testing Market: End-use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Employer and Workplace Drug Testing Market End-use Movement Analysis
  • 8.2.1. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 8.3. IT/Finance
  • 8.3.1. IT/finance market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Manufacturing
  • 8.4.1. Manufacturing market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Transportation
  • 8.5.1. Transportation market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Construction
  • 8.6.1. Construction market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Retail and Hospitality
  • 8.7.1. Retail and hospitality market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Healthcare
  • 8.8.1. Healthcare market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. Education
  • 8.9.1. Education surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
• 8.10. Other Professional Services
  • 8.10.1. Other Professional Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Employer and Workplace Drug Testing Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.3. North America
  • 9.3.1. U.S.
    • 9.3.1.1. Key country dynamics
    • 9.3.1.2. Regulatory framework/ reimbursement structure
    • 9.3.1.3. Competitive scenario
    • 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.2. Canada
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Regulatory framework/ reimbursement structure
    • 9.3.2.3. Competitive scenario
    • 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.3. Mexico
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Regulatory framework/ reimbursement structure
    • 9.3.3.3. Competitive scenario
    • 9.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Regulatory framework/ reimbursement structure
    • 9.4.1.3. Competitive scenario
    • 9.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework/ reimbursement structure
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework/ reimbursement structure
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework/ reimbursement structure
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Regulatory framework/ reimbursement structure
    • 9.4.5.3. Competitive scenario
    • 9.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.6. Norway
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Regulatory framework/ reimbursement structure
    • 9.4.6.3. Competitive scenario
    • 9.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Regulatory framework/ reimbursement structure
    • 9.4.7.3. Competitive scenario
    • 9.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Regulatory framework/ reimbursement structure
    • 9.4.8.3. Competitive scenario
    • 9.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework/ reimbursement structure
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework/ reimbursement structure
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. India
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework/ reimbursement structure
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.4. Australia
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework/ reimbursement structure
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework/ reimbursement structure
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework/ reimbursement structure
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework/ reimbursement structure
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework/ reimbursement structure
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework/ reimbursement structure
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework/ reimbursement structure
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework/ reimbursement structure
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework/ reimbursement structure
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Share Analysis, 2023
• 10.4. List of Key Certification Providers/Scheme Owners
• 10.5. Company Profiles/Listing
  • 10.5.1. First Advantage
    • 10.5.1.1. Company overview
    • 10.5.1.2. Financial performance
    • 10.5.1.3. Product benchmarking
    • 10.5.1.4. Strategic initiatives
  • 10.5.2. Laboratory Corporation of America Holdings (Labcorp)
    • 10.5.2.1. Company overview
    • 10.5.2.2. Financial performance
    • 10.5.2.3. Product benchmarking
    • 10.5.2.4. Strategic initiatives
  • 10.5.3. Dragerwerk AG & Co. KGaA
    • 10.5.3.1. Company overview
    • 10.5.3.2. Financial performance
    • 10.5.3.3. Product benchmarking
    • 10.5.3.4. Strategic initiatives
  • 10.5.4. Bio-Rad Laboratories, Inc.
    • 10.5.4.1. Company overview
    • 10.5.4.2. Financial performance
    • 10.5.4.3. Product benchmarking
    • 10.5.4.4. Strategic initiatives
  • 10.5.5. Abbott
    • 10.5.5.1. Company overview
    • 10.5.5.2. Financial performance
    • 10.5.5.3. Product benchmarking
    • 10.5.5.4. Strategic initiatives
  • 10.5.6. Clinical Reference Laboratory Inc.
    • 10.5.6.1. Company overview
    • 10.5.6.2. Financial performance
    • 10.5.6.3. Product benchmarking
    • 10.5.6.4. Strategic initiatives
  • 10.5.7. Quest Diagnostics
    • 10.5.7.1. Company overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Product benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. Cordant Health Solutions
    • 10.5.8.1. Company overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Product benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. DISA Global Solutions
    • 10.5.9.1. Company overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Product benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. HireRight, LLC
    • 10.5.10.1. Company overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Product benchmarking
    • 10.5.10.4. Strategic initiatives
  • 10.5.11. OraSure Technologies, Inc.
    • 10.5.11.1. Company overview
    • 10.5.11.2. Financial performance
    • 10.5.11.3. Product benchmarking
    • 10.5.11.4. Strategic initiatives
  • 10.5.12. Psychemedics Corporation
    • 10.5.12.1. Company overview
    • 10.5.12.2. Financial performance
    • 10.5.12.3. Product benchmarking
    • 10.5.12.4. Strategic initiatives
  • 10.5.13. Omega Laboratories
    • 10.5.13.1. Company overview
    • 10.5.13.2. Financial performance
    • 10.5.13.3. Product benchmarking
    • 10.5.13.4. Strategic initiatives